ArticleCureus2025
Breast Cancer Metastasis to the Optic Nerve: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Optic nerve metastases from breast cancer are an extremely rare event, with very limited cases reported in the literature. In this report, we present the case of a 64-year-old woman with a history of hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative invasive lobular carcinoma of the breast, who developed bilateral progressive vision loss almost 10 years after her initial diagnosis. Despite previous treatment using surgery, chemotherapy, radiotherapy, and hormone therapy, the progression of the disease included brain, lung, and bone metastases. The patient suffered from blurred vision that rapidly worsened, leading to complete blindness. Bilateral optic atrophy was noted on ophthalmological evaluation, and MRI findings included nodular thickening and enhancement of the pre-chiasmatic optic nerves, which were consistent with metastatic involvement. Due to her poor general condition, she was put on weekly paclitaxel systemic chemotherapy, with no indication for surgery. This is a unique case, as it highlights optic nerve metastasis as a late manifestation of lobular breast cancer and underlines the significance of considering metastatic disease in patients with newly presenting visual symptoms and a history of breast cancer. The main lesson to be learned from this report is that early detection and multidisciplinary evaluation are crucial to optimize the patient's care, despite the fact that therapeutic options may be limited at an advanced stage of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.